These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15556002)

  • 21. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
    Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1.
    Lee JH; Lee IH; Choe YJ; Kang S; Kim HY; Gai WP; Hahn JS; Paik SR
    Biochem J; 2009 Mar; 418(2):311-23. PubMed ID: 19007333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration.
    Li HT; Lin DH; Luo XY; Zhang F; Ji LN; Du HN; Song GQ; Hu J; Zhou JW; Hu HY
    FEBS J; 2005 Jul; 272(14):3661-72. PubMed ID: 16008565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of oligomeric intermediates in alpha-synuclein fibrillation: FRET studies of Y125W/Y133F/Y136F alpha-synuclein.
    Kaylor J; Bodner N; Edridge S; Yamin G; Hong DP; Fink AL
    J Mol Biol; 2005 Oct; 353(2):357-72. PubMed ID: 16171820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
    Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T
    Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-synuclein has structural and functional similarities to small heat shock proteins.
    Kim TD; Choi E; Rhim H; Paik SR; Yang CH
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1352-9. PubMed ID: 15504363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAMAM dendrimers as potential agents against fibrillation of alpha-synuclein, a Parkinson's disease-related protein.
    Rekas A; Lo V; Gadd GE; Cappai R; Yun SI
    Macromol Biosci; 2009 Mar; 9(3):230-8. PubMed ID: 19116892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
    Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
    Mishizen-Eberz AJ; Norris EH; Giasson BI; Hodara R; Ischiropoulos H; Lee VM; Trojanowski JQ; Lynch DR
    Biochemistry; 2005 May; 44(21):7818-29. PubMed ID: 15909996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
    Kong B; Chae Y; Lee K
    Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
    Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R
    J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.
    Lee HJ; Suk JE; Bae EJ; Lee JH; Paik SR; Lee SJ
    Int J Biochem Cell Biol; 2008; 40(9):1835-49. PubMed ID: 18291704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.
    Kamiyoshihara T; Kojima M; Uéda K; Tashiro M; Shimotakahara S
    Biochem Biophys Res Commun; 2007 Apr; 355(2):398-403. PubMed ID: 17300751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers.
    Danzer KM; Schnack C; Sutcliffe A; Hengerer B; Gillardon F
    J Neurochem; 2007 Dec; 103(6):2401-7. PubMed ID: 17883396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA induces folding in alpha-synuclein: understanding the mechanism using chaperone property of osmolytes.
    Hegde ML; Rao KS
    Arch Biochem Biophys; 2007 Aug; 464(1):57-69. PubMed ID: 17537399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL; Przedborski S; Petrucelli L
    Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.